Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated TMS for MDD

NCT: NCT07147218 · ACTIVE_NOT_RECRUITING

NCT IDNCT07147218
StatusACTIVE_NOT_RECRUITING
Start Date2025-08-21
Completion2027-12-31
SponsorNeuronetics (OTHER)
First posted
Last updated

Brief Summary

An open-label, multi-center, prospective study to evaluate feasibility and efficacy of accelerated TMS for patients with Major Depressive Disorder (MDD).

Frequently Asked Questions

What is Accelerated TMS for MDD?

Accelerated TMS for MDD is a clinical trial registered under NCT07147218. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07147218?

The current status of NCT07147218 (Accelerated TMS for MDD) is: ACTIVE_NOT_RECRUITING.

When did Accelerated TMS for MDD start?

Accelerated TMS for MDD started on 2025-08-21.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.